articleAmerican Journal of Physiology-Cell PhysiologyApr 8, 2009Closed access

Myostatin reduces Akt/TORC1/p70S6K signaling, inhibiting myoblast differentiation and myotube size

Novartis (Switzerland) · Novartis Institutes for BioMedical Research

PubMed
Indexed incrossrefpubmed

Abstract

Myostatin is a negative regulator of skeletal muscle size, previously shown to inhibit muscle cell differentiation. Myostatin requires both Smad2 and Smad3 downstream of the activin receptor II (ActRII)/activin receptor-like kinase (ALK) receptor complex. Other transforming growth factor-beta (TGF-beta)-like molecules can also block differentiation, including TGF-beta(1), growth differentiation factor 11 (GDF-11), activins, bone morphogenetic protein 2 (BMP-2) and BMP-7. Myostatin inhibits activation of the Akt/mammalian target of rapamycin (mTOR)/p70S6 protein synthesis pathway, which mediates both differentiation in myoblasts and hypertrophy in myotubes. Blockade of the Akt/mTOR pathway, using small…

Citation impact

773
total citations
FWCI
18.48
Percentile
100%
References
54
Citations per year

Authors

6

Topics & keywords

Keywords
  • Myostatin
  • Protein kinase B
  • Cell biology
  • C2C12
  • Signal transduction
  • Biology
  • Myocyte
  • Endocrinology
No related works found for this paper.